Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Abstract
In the last decade, induced pluripotent stem (iPS) cells have revolutionized the utility of human in vitro models of neurological disease. The iPS-derived and differentiated cells allow researchers to study the impact of a distinct cell type in health and disease as well as performing therapeutic drug screens on a human genetic background. In particular, clinical trials for Alzheimer’s disease (AD) have been often failing. Two of the potential reasons are first, the species gap involved in proceeding from initial discoveries in rodent models to human studies, and second, an unsatisfying patient stratification, meaning subgrouping patients based on the disease severity due to the lack of phenotypic and genetic markers. iPS cells overcome this obstacles and will improve our understanding of disease subtypes in AD. They allow researchers conducting in depth characterization of neural cells from both familial and sporadic AD patients as well as preclinical screens on human cells. In this review, we briefly outline the status quo of iPS cell research in neurological diseases along with the general advantages and pitfalls of these models. We summarize how genome-editing techniques such as CRISPR/Cas will allow researchers to reduce the problem of genomic variability inherent to human studies, followed by recent iPS cell studies relevant to AD. We then focus on current techniques for the differentiation of iPS cells into neural cell types that are relevant to AD research. Finally, we discuss how the generation of three-dimensional cell culture systems will be important for understanding AD phenotypes in a complex cellular milieu, and how both two- and three-dimensional iPS cell models can provide platforms for drug discovery and translational studies into the treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“(2015), http://dx.doi.org/10.1016/j.mcn.2015.11.010 or repressors also allow us to examine the consequences of enhanced or suppressed expression of specific genes without alterations to the genome itself (Qi et al., 2013).”
BackgroundInfluentialZhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“…1 and 2 (PSEN1, PSEN2), which are part of the γ-secretase complex (Levy-Lahad et al., 1995a; Levy-Lahad et al., 1995b; Rogaev et al., 1995; Schellenberg et al., 1993), ormutations within or duplications of the APP gene itself (Goate et al., 1991; Goate, 2006; St George-Hyslop et al., 1987).”
BackgroundThe precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · cited 1×
“Amyloid plaques are extracellular accumulations of β-amyloid (Aβ) peptides that are derived from the proteolytic processing of the βamyloid precursor protein (APP) (Goldgaber et al., 1987; Kang et al., 1987; Robakis et al., 1987; Tanzi et al., 1987).”
BackgroundMeta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · cited 1×
“Apolipoprotein (APOE) was originally identified in the liver, where it mediates the transport and delivery of cholesterol and other lipids through cell surface ApoE receptors (Mahley, 1988; Mahley and Rall, 2000).”
BackgroundAssociation of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · cited 1×
“…et al., 2008; Bradshaw et al., 2013; Calero et al., 2000; Corneveaux et al., 2010; Crehan et al., 2013; Deng et al., 2012; Guerreiro et al., 2013; Harold et al., 2009; Hollingworth et al., 2011; Jonsson et al., 2013; Lambert et al., 2009; Lambert et al., 2010; Wunderlich et al., 2013; N. Zhang,…”
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153 · cited 3×
“…of the second generation TALEN technique overcame some of the limitations of the ZFNs by being less context-dependent and easier to design (Joung and Sander, 2013; Miller et al., 2011; Sander and Joung, 2014), while the efficiency is similar between the two paradigms (Hockemeyer et al., 2011).”
BackgroundMethodCahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129 · cited 1×
“…of neural systems: for example, neurons exhibit increased synapse formation when they are co-cultured with astrocytes (Pfrieger and Barres, 1997), and astrocytes may look and behave differently in two-dimensional culture than they do in the brain (Cahoy et al., 2008; Puschmann et al., 2013).”
BackgroundTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 1×
“…et al., 2011; Bertram et al., 2008; Bradshaw et al., 2013; Calero et al., 2000; Corneveaux et al., 2010; Crehan et al., 2013; Deng et al., 2012; Guerreiro et al., 2013; Harold et al., 2009; Hollingworth et al., 2011; Jonsson et al., 2013; Lambert et al., 2009; Lambert et al., 2010; Wunderlich…”
BackgroundGenetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“…et al., 2013; Calero et al., 2000; Corneveaux et al., 2010; Crehan et al., 2013; Deng et al., 2012; Guerreiro et al., 2013; Harold et al., 2009; Hollingworth et al., 2011; Jonsson et al., 2013; Lambert et al., 2009; Lambert et al., 2010; Wunderlich et al., 2013; N. Zhang, 2010; Q. Zhang, 2010).”
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414 · cited 1×
“Algorithms have been developed that predict off target effects of CRISPR-mediated genome editing, which, combined with falling costs for deep sequencing, allow researchers to minimize off-target effects (Hsu et al., 2013; Tsai et al., 2015; Slaymaker et al., 2015).”
BackgroundGenome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196 · cited 2×
“…Juvenile diabetes mellitus, Huntington disease (Consortium, 2012; N. Zhang, 2010; Q. Zhang, 2010), and Lesch–Nyhan syndrome (Mattis et al., 2015; Park et al., 2008) and AD (Choi et al., 2014; Hossini et al., 2015; Iovino Please cite this article as: Mungenast, A.E., et al., Modeling…”
BackgroundTau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · cited 1×
“The second defining characteristic of AD is the presence of neurofibrillary tangles (NFTs) comprised of intracellular accumulations of the microtubule-associated protein tau in affected neurons (Ballatore et al., 2007).”
BackgroundVascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
The glymphatic system: a beginner's guide
Jessen, N. A., Munk, A. S. F., Lundgaard, I., & Nedergaard, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1581-6 · Cited by 2,075 · cited 1×
“…and synapse maintenance (Haydon and Nedergaard, 2015; Pascual et al., 2005; Perea et al., 2009), maintain brain homeostasis, store and distribute energy substrates, and play a major role in the clearance of metabolites and toxins from the brain parenchyma (Jessen et al., 2015; Xie et al., 2013).”
BackgroundSynaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070 · cited 1×
“…research, since both inhibitory and excitatory neurons are affected (Hazra et al., 2013; Krantic et al., 2012), and inhibitory interneurons, such as parvalbuminergic cells, play crucial roles in orchestrating large networks crucial to memory formation (Bartos et al., 2007; Mann and Paulsen, 2007).”
BackgroundRogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052 · cited 1×
“…processing enzymes, presenilin 1 and 2 (PSEN1, PSEN2), which are part of the γ-secretase complex (Levy-Lahad et al., 1995a; Levy-Lahad et al., 1995b; Rogaev et al., 1995; Schellenberg et al., 1993), ormutations within or duplications of the APP gene itself (Goate et al., 1991; Goate, 2006; St…”
BackgroundJarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · cited 1×
“Of these, Aβ40 is the most abundant in both healthy and AD brain tissue, whereas the Aβ42 variant has been shown to be likely the most deleterious (Jarrett et al., 1993; Portelius et al., 2010).”
BackgroundInitiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Gene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“Much work has begun in this direction, and large-scale human genome-wide association studies (GWAS) combined with mouse and human epigenetic and transcriptome profiling, have derived lists of genes in which variants are consistently associated with an increased risk of AD (Bertram et al., 2007).”
BackgroundTripartite synapses: astrocytes process and control synaptic information
Perea, G., Navarrete, M., & Araque, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.001 · Cited by 1,820 · cited 1×
“Astrocytes are intimately involved in synaptogenesis and synapse maintenance (Haydon and Nedergaard, 2015; Pascual et al., 2005; Perea et al., 2009), maintain brain homeostasis, store and distribute energy substrates, and play a major role in the clearance of metabolites and toxins from the brain…”
BackgroundRole of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798 · cited 1×
“While 60–80% of sAD may in fact have genetic underpinnings (Gatz et al., 2006), one's APOE genotype remains the only known robust factor affecting sAD risk.”
BackgroundPhase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
TALENs: A widely applicable technology for targeted genome editing
Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650 · cited 2×
“TALEN technique overcame some of the limitations of the ZFNs by being less context-dependent and easier to design (Joung and Sander, 2013; Miller et al., 2011; Sander and Joung, 2014), while the efficiency is similar between the two paradigms (Hockemeyer et al.”
ResultRapid single-step induction of functional neurons from human pluripotent stem cells
Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., Marro, S., Patzke, C., Acuna, C., Covy, J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.029 · Cited by 1,644 · cited 2×
“…these lines, some groups have found that the addition of astrocytes to iPS cell-derived neuronal cultures enhances the ability to obtain mature neurons (Odawara et al., 2014; B. Zhang et al., 2013; Y. Zhang et al., 2013); this is an area of active debate and constant methodological improvement.”
BackgroundAmyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture
Paşca, A. M., Sloan, S. A., Clarke, L. E., Tian, Y., Makinson, C. D., Huber, N., Kim, C. H., Park, J.-Y., O'Rourke, N. A., Nguyen, K. D., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3415 · Cited by 1,609 · cited 1×
“To overcome this, recent studies have embedded human ES or iPS cell-derived cells in scaffolding such as hydrogel or Matrigel, to create three dimensional culture systems (Pasca et al., 2015; Schwartz et al., 2015; Smith et al., 2015).”
MethodEiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., Wataya, T., Nishiyama, A., Muguruma, K., & Sasai, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.002 · Cited by 1,522
Uniquely Hominid Features of Adult Human Astrocytes
Oberheim, N. A., Takano, T., Han, X., He, W., Lin, J. H. C., Wang, F., Xu, Q., Wyatt, J. D., Pilcher, W., Ojemann, J. G., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4707-08.2009 · Cited by 1,488
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474 · cited 2×
“Mutations in the gene encoding tau (MAPT) have been found to be causal for fronto-temporal dementia, although MAPT mutations have not been described in AD (Hutton et al., 1998; Spillantini et al., 1998).”
BackgroundInduced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
Marchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H., & Muotri, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.10.016 · Cited by 1,329
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280 · cited 1×
“Astrocytes are intimately involved in synaptogenesis and synapse maintenance (Haydon and Nedergaard, 2015; Pascual et al., 2005; Perea et al., 2009), maintain brain homeostasis, store and distribute energy substrates, and play a major role in the clearance of metabolites and toxins from the brain…”
BackgroundProbing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance
Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,242 · cited 1×
“In both humans and in animal models, the APOE4 allele is associated with increased levels of amyloid beta (Aβ), as well as amyloid plaque deposition (Castellano et al., 2011; Fryer et al., 2005; Kim et al., 2009; Youmans et al., 2012).”
BackgroundA Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Doody, R. S., Raman, R., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., He, F., Sun, X., Thomas, R. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1210951 · Cited by 1,224
A three-dimensional human neural cell culture model of Alzheimer’s disease
Choi, S. H., Kim, Y. H., Hebisch, M., Sliwinski, C., Lee, S., D’Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., et al. (2014) · Nature · doi:10.1038/nature13800 · Cited by 1,195 · cited 7×
“Neurons Cellular/oxidative stress, Cellular aging, Lewy-body-precursor-like inclusions, DNA damage, Mitochondrial dysfunction RNA-Seq Choi et al. (2014) Kim 2014 25307057 ReN cell VM human neural stem (ReN) cells (Millipore) fAD Overexpression of APP K670N/M671L/V717I; PSEN1(ΔE9) 3D neural culture in Matrigel Aβ, Tau,…”
BackgroundResultInfluentialApolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168
Genome Engineering With Zinc-Finger Nucleases
Carroll, D. (2011) · Genetics · doi:10.1534/genetics.111.131433 · Cited by 1,076
Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., & Landfield, P. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308512100 · Cited by 1,025
Kadoshima, T., Sakaguchi, H., Nakano, T., Soen, M., Ando, S., Eiraku, M., & Sasai, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315710110 · Cited by 999 · cited 1×
“…cells (Choi et al., 2014), or the creation of selforganizing neural tissue structures in vitro (Eiraku and Sasai, 2012; Eiraku et al., 2008; Kadoshima et al., 2013; Lancaster et al., 2013; Lancaster and Knoblich, 2014), hold great promise for modeling the intricatemicro-…”
BackgroundShi, Y., Kirwan, P., & Livesey, F. J. (2012) · Nature Protocols · doi:10.1038/nprot.2012.116 · Cited by 972
New insights into the classification and nomenclature of cortical GABAergic interneurons
DeFelipe, J., López-Cruz, P. L., Benavides-Piccione, R., Bielza, C., Larrañaga, P., Anderson, S., Burkhalter, A., Cauli, B., Fairén, A., Feldmeyer, D., et al. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3444 · Cited by 833
Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses
Shi, Y., Kirwan, P., Smith, J., Robinson, H. P. C., & Livesey, F. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3041 · Cited by 813
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800
Human iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
Linking functional decline of telomeres, mitochondria and stem cells during ageing
Sahin, E., & DePinho, R. A. (2010) · Nature · doi:10.1038/nature08982 · Cited by 759 · cited 2×
“…their genomic integrity appears to be a hallmark both of normal aging and of neurodegenerative disease (Dobbin et al., 2013; Goto, 1997; Hasty et al., 2003; Kim et al., 2008; Lovell and Markesbery, 2007; Lu et al., 2004; Sahin and DePinho, 2010; S. Wang et al., 2013; W.Y. Wang et al., 2013).”
BackgroundWebster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755 · cited 1×
“(2015), http://dx.doi.org/10.1016/j.mcn.2015.11.010 drawback to these models is that they typically only capture specific aspects of AD phenotypes such as Aβ plaques or NFTs, but rarely the entire disease spectrum (Webster et al., 2014).”
BackgroundInfluentialThirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747 · cited 1×
“Individuals with one APOE4 allele are three to four times more likely to develop AD than those without APOE4 alleles, an odds ratio that is by far the highest out of any AD risk gene (Bertram and Tanzi, 2008; Corder et al., 1993).”
BackgroundKondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741
Soldner, F., Laganière, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L. I., Myers, R. H., Lindquist, S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.019 · Cited by 728
Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727 · cited 1×
“Also, microglia are demonstrated to undergo apoptosis in AD brain (Lassmann et al., 1995; Sugaya et al., 1997; Yang et al., 1998) and show dystrophic morphology and fragmentation, which could underlie senescence in these cells (Streit et al., 2009; Streit and Xue, 2010).”
BackgroundGeneration of human induced pluripotent stem cells from urine samples
Zhou, T., Benda, C., Dunzinger, S., Huang, Y., Ho, J. C., Yang, J., Wang, Y., Zhang, Y., Zhuang, Q., Li, Y., et al. (2012) · Nature Protocols · doi:10.1038/nprot.2012.115 · Cited by 614
ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
Kanekiyo, T., Xu, H., & Bu, G. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.045 · Cited by 608 · cited 1×
“…have a frequency in the population of 8.4% (ε2), 77.9% (ε3), and 13.7% (ε4), the frequency of the APOE ε4 variant (APOE4) is increased to at least 40% in sporadic AD patients (Farrer et al., 1997) making it the greatest known risk factor for sAD (Kanekiyo et al., 2014; Lambert et al., 2013).”
InfluentialModeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599
Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Studer, L., Hochedlinger, K., Windrem, M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.002 · Cited by 586
Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0003 · Cited by 584 · cited 1×
“The underlying reasons for this are not clear, but are presumably related to the triplication of the APP gene, as well as the tau kinase DYRK1A gene (Woods et al., 2001) on chromosome 21 (Beyreuther et al., 1993; Burger and Vogel, 1973; Lemere et al., 1996; Rumble et al., 1989).”
BackgroundConserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease
Gjoneska, E., Pfenning, A. R., Mathys, H., Quon, G., Kundaje, A., Tsai, L.-H., & Kellis, M. (2015) · Nature · doi:10.1038/nature14252 · Cited by 576 · cited 1×
“Overall, human AD and mouse gene expression studies show that, with AD progression, immune response and inflammatory genes are up- and genes involved in neuronal functions are down-regulated (Blalock et al., 2011; Blalock et al., 2004; Gjoneska et al., 2015).”
BackgroundSelf-citationRecapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome
Liu, G.-H., Barkho, B. Z., Ruiz, S., Diep, D., Qu, J., Yang, S.-L., Panopoulos, A. D., Suzuki, K., Kurian, L., Walsh, C., et al. (2011) · Nature · doi:10.1038/nature09879 · Cited by 575
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Initiative, T. A. D. N., Bradshaw, E. M., Chibnik, L. B., Keenan, B. T., Ottoboni, L., Raj, T., Tang, A., Rosenkrantz, L. L., Imboywa, S., Lee, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3435 · Cited by 570
Aging and Genome Maintenance: Lessons from the Mouse?
Hasty, P., Campisi, J., Hoeijmakers, J., van Steeg, H., & Vijg, J. (2003) · Science · doi:10.1126/science.1079161 · Cited by 553 · cited 1×
“…to maintain their genomic integrity appears to be a hallmark both of normal aging and of neurodegenerative disease (Dobbin et al., 2013; Goto, 1997; Hasty et al., 2003; Kim et al., 2008; Lovell and Markesbery, 2007; Lu et al., 2004; Sahin and DePinho, 2010; S. Wang et al., 2013; W.Y. Wang et al.,…”
BackgroundSynaptic dysregulation in a human iPS cell model of mental disorders
Wen, Z., Nguyen, H. N., Guo, Z., Lalli, M. A., Wang, X., Su, Y., Kim, N.-S., Yoon, K.-J., Shin, J., Zhang, C., et al. (2014) · Nature · doi:10.1038/nature13716 · Cited by 549
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546 · cited 1×
“White matter lesions and myelin abnormalities have been described in human AD brain and mouse models (Bartzokis, 2011; Desai et al., 2010; Desai et al., 2009; Englund et al., 1988; Kobayashi et al., 2002; Roth et al., 2005).”
BackgroundLocal Ca2+ detection and modulation of synaptic release by astrocytes
Di Castro, M. A., Chuquet, J., Liaudet, N., Bhaukaurally, K., Santello, M., Bouvier, D., Tiret, P., & Volterra, A. (2011) · Nature Neuroscience · doi:10.1038/nn.2929 · Cited by 529
Bertram, L., Lange, C., Mullin, K., Parkinson, M., Hsiao, M., Hogan, M. F., Schjeide, B. M. M., Hooli, B., DiVito, J., Ionita, I., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.10.008 · Cited by 511 · cited 6×
“Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.”
BackgroundInfluentialLippmann, E. S., Al-Ahmad, A., Azarin, S. M., Palecek, S. P., & Shusta, E. V. (2014) · Scientific Reports · doi:10.1038/srep04160 · Cited by 508 · cited 1×
“…multiple research groups are focusing on creating vascularization, as shown for liver tissue (Masumoto et al., 2014; Samuel et al., 2013; Takebe et al., 2013) or blood–brain-barrier structures from iPS cells (Lippmann et al., 2014; Lippmann et al., 2013; Lippmann et al., 2012; Minami et al., 2015).”
BackgroundProteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455
Spine neck plasticity regulates compartmentalization of synapses
Tønnesen, J., Katona, G., Rózsa, B., & Nägerl, U. V. (2014) · Nature Neuroscience · doi:10.1038/nn.3682 · Cited by 444 · cited 1×
“The latter is a concern for all cell types, since neurons and glia both utilize subcellular specializations, or compartmentalization, to function properly in vivo (Khakh and McCarthy, 2015; Tonnesen et al., 2014).”
BackgroundDevelopment of a Method for the Purification and Culture of Rodent Astrocytes
Foo, L. C., Allen, N. J., Bushong, E. A., Ventura, P. B., Chung, W.-S., Zhou, L., Cahoy, J. D., Daneman, R., Zong, H., Ellisman, M. H., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.022 · Cited by 433
Muratore, C. R., Rice, H. C., Srikanth, P., Callahan, D. G., Shin, T., Benjamin, L. N. P., Walsh, D. M., Selkoe, D. J., & Young-Pearse, T. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu064 · Cited by 379 · cited 3×
“…neurons, neurospheres Synapse number, NPC viability, DYRK1A activity, neurogenesis, differentiation epigallocatechine gallate (EGCG) RNA-Seq Muratore et al. (2014) Young-Pearse 2014 24524897 iPSCs: hFibs from HSCI fAD APP V717I iPSCs, NPCs, Neurons Aβ, Tau, APP cleavage, endosomes DAPT,…”
InfluentialBernardinelli, Y., Randall, J., Janett, E., Nikonenko, I., König, S., Jones, E. V., Flores, C. E., Murai, K. K., Bochet, C. G., Holtmaat, A., et al. (2014) · Current Biology · doi:10.1016/j.cub.2014.06.025 · Cited by 369
LI, S., MALLORY, M., ALFORD, M., TANAKA, S., & MASLIAH, E. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00008 · Cited by 343
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
Liu, G.-H., Qu, J., Suzuki, K., Nivet, E., Li, M., Montserrat, N., Yi, F., Xu, X., Ruiz, S., Zhang, W., et al. (2012) · Nature · doi:10.1038/nature11557 · Cited by 339
Human pluripotent stem cell-derived neural constructs for predicting neural toxicity
Schwartz, M. P., Hou, Z., Propson, N. E., Zhang, J., Engstrom, C. J., Costa, V. S., Jiang, P., Nguyen, B. K., Bolin, J. M., Daly, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516645112 · Cited by 325
Dynamics and Mechanisms of CNS Myelination
Bercury, K. K., & Macklin, W. B. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.016 · Cited by 320
A Human Stem Cell Model of Early Alzheimer’s Disease Pathology in Down Syndrome
Shi, Y., Kirwan, P., Smith, J., MacLean, G., Orkin, S. H., & Livesey, F. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003771 · Cited by 310
Douvaras, P., Wang, J., Zimmer, M., Hanchuk, S., O’Bara, M. A., Sadiq, S., Sim, F. J., Goldman, J., & Fossati, V. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.06.012 · Cited by 302 · cited 2×
“…of heterogeneous cultures (Hu et al., 2009; Kim et al., 2012; Swistowski et al., 2010) or as the result of concerted efforts to generate these particular cell types (Douvaras et al., 2014; Jang et al., 2011; Ogawa et al., 2011; Pouya et al., 2011; S. Wang et al., 2013; X.Y. Wang et al., 2013).”
BackgroundWunderlich, P., Glebov, K., Kemmerling, N., Tien, N. T., Neumann, H., & Walter, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517540 · Cited by 296 · cited 5×
“Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.”
BackgroundInfluentialGenetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells
Rouhani, F., Kumasaka, N., de Brito, M. C., Bradley, A., Vallier, L., & Gaffney, D. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004432 · Cited by 294
Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity
Kim, D., Frank, C. L., Dobbin, M. M., Tsunemoto, R. K., Tu, W., Peng, P. L., Guan, J.-S., Lee, B.-H., Moy, L. Y., Giusti, P., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.015 · Cited by 286
Self-citationFryer, J. D., Simmons, K., Parsadanian, M., Bales, K. R., Paul, S. M., Sullivan, P. M., & Holtzman, D. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5170-04.2005 · Cited by 278 · cited 1×
“While 60–80% of sAD may in fact have genetic underpinnings (Gatz et al., 2006), one's APOE genotype remains the only known robust factor affecting sAD risk.”
BackgroundFischer, A., Sananbenesi, F., Pang, P. T., Lu, B., & Tsai, L.-H. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.033 · Cited by 277
Self-citationA 3D human neural cell culture system for modeling Alzheimer's disease
Kim, Y. H., Choi, S. H., D'Avanzo, C., Hebisch, M., Sliwinski, C., Bylykbashi, E., Washicosky, K. J., Klee, J. B., Brüstle, O., Tanzi, R. E., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2015.065 · Cited by 269
APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease
Youmans, K. L., Tai, L. M., Nwabuisi-Heath, E., Jungbauer, L., Kanekiyo, T., Gan, M., Kim, J., Eimer, W. A., Estus, S., Rebeck, G. W., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407957 · Cited by 268 · cited 1×
“In both humans and in animal models, the APOE4 allele is associated with increased levels of amyloid beta (Aβ), as well as amyloid plaque deposition (Castellano et al., 2011; Fryer et al., 2005; Kim et al., 2009; Youmans et al., 2012).”
BackgroundEthical issues in stem cell research and therapy
King, N. M., & Perrin, J. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt474 · Cited by 267 · cited 1×
“This said, the ability to access patient history in the use of iPS cell research is highly variable between research groups and subject to a great deal of regulation to ensure patient privacy (King and Perrin, 2014; Lomax et al., 2015; Lomax and Peckman, 2012; Lomax et al., 2013).”
BackgroundDesai, M. K., Sudol, K. L., Janelsins, M. C., Mastrangelo, M. A., Frazer, M. E., & Bowers, W. J. (2009) · Glia · doi:10.1002/glia.20734 · Cited by 266 · cited 1×
“White matter lesions and myelin abnormalities have been described in human AD brain and mouse models (Bartzokis, 2011; Desai et al., 2010; Desai et al., 2009; Englund et al., 1988; Kobayashi et al., 2002; Roth et al., 2005).”
BackgroundSIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons
Dobbin, M. M., Madabhushi, R., Pan, L., Chen, Y., Kim, D., Gao, J., Ahanonu, B., Pao, P.-C., Qiu, Y., Zhao, Y., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3460 · Cited by 250
Self-citationHierarchical deterioration of body systems in Werner's syndrome: Implications for normal ageing
Goto, M. (1997) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(97)00111-5 · Cited by 240 · cited 2×
“…of neurons to maintain their genomic integrity appears to be a hallmark both of normal aging and of neurodegenerative disease (Dobbin et al., 2013; Goto, 1997; Hasty et al., 2003; Kim et al., 2008; Lovell and Markesbery, 2007; Lu et al., 2004; Sahin and DePinho, 2010; S. Wang et al., 2013; W.Y.…”
BackgroundCorneveaux, J. J., Myers, A. J., Allen, A. N., Pruzin, J. J., Ramirez, M., Engel, A., Nalls, M. A., Chen, K., Lee, W., Chewning, K., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq221 · Cited by 237 · cited 1×
“…APOE, PICALM, TREM2, CR1, CD33 and CLU (Ando et al., 2013; Antunez et al., 2011; Bertram et al., 2008; Bradshaw et al., 2013; Calero et al., 2000; Corneveaux et al., 2010; Crehan et al., 2013; Deng et al., 2012; Guerreiro et al., 2013; Harold et al., 2009; Hollingworth et al., 2011; Jonsson et…”
BackgroundDesai, M. K., Mastrangelo, M. A., Ryan, D. A., Sudol, K. L., Narrow, W. C., & Bowers, W. J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100087 · Cited by 232 · cited 1×
“White matter lesions and myelin abnormalities have been described in human AD brain and mouse models (Bartzokis, 2011; Desai et al., 2010; Desai et al., 2009; Englund et al., 1988; Kobayashi et al., 2002; Roth et al., 2005).”
BackgroundThe study of eQTL variations by RNA-seq: from SNPs to phenotypes
Majewski, J., & Pastinen, T. (2011) · Trends in Genetics · doi:10.1016/j.tig.2010.10.006 · Cited by 232
WHITE MATTER CHANGES IN DEMENTIA OF ALZHEIMER'S TYPE: BIOCHEMICAL AND NEUROPATHOLOGICAL CORRELATES
ENGLUND, E., BRUN, A., & ALLING, C. (1988) · Brain · doi:10.1093/brain/111.6.1425 · Cited by 228
Chen, C., Jiang, P., Xue, H., Peterson, S. E., Tran, H. T., McCann, A. E., Parast, M. M., Li, S., Pleasure, D. E., Laurent, L. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms5430 · Cited by 219 · cited 1×
“Tomore quickly obtain cultures with a higher purity of astrocytes, techniques have been developed to obtain astrocytes from gliospheres (Krencik et al., 2011) or by directed differentiation via defined factors (Chen et al., 2014).”
MethodBlalock, E. M., Buechel, H. M., Popovic, J., Geddes, J. W., & Landfield, P. W. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.06.007 · Cited by 211
Deficits in human trisomy 21 iPSCs and neurons
Weick, J. P., Held, D. L., Bonadurer, G. F., Doers, M. E., Liu, Y., Maguire, C., Clark, A., Knackert, J. A., Molinarolo, K., Musser, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216575110 · Cited by 205
Aging and reprogramming: a two-way street
Mahmoudi, S., & Brunet, A. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.10.004 · Cited by 171 · cited 2×
“Work by several groups has suggested that reprogramming of the iPS cells “re-sets” the epigenome, and that other phenotypes associated with cellular aging, such asmitochondrial function and telomere length, are returned to a “juvenile-like” state (Mahmoudi and Brunet, 2012; Miller and Studer, 2014).”
BackgroundZhang, D., Pekkanen-Mattila, M., Shahsavani, M., Falk, A., Teixeira, A. I., & Herland, A. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.028 · Cited by 171
Hibaoui, Y., Grad, I., Letourneau, A., Sailani, M. R., Dahoun, S., Santoni, F. A., Gimelli, S., Guipponi, M., Pelte, M. F., Béna, F., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201302848 · Cited by 170 · cited 4×
“The issue of altered proliferation and/or differentiation of neural progenitor cells and neurons seems particularly troublesome in work with Down syndrome lines (Hibaoui et al., 2014; Murray et al., 2015).”
BackgroundInfluentialIovino, M., Agathou, S., González-Rueda, A., Del Castillo Velasco-Herrera, M., Borroni, B., Alberici, A., Lynch, T., O’Dowd, S., Geti, I., Gaffney, D., et al. (2015) · Brain · doi:10.1093/brain/awv222 · Cited by 155
Implication of the Immune System in Alzheimer's Disease: Evidence from Genome-Wide Pathway Analysis
Lambert, J.-C., Grenier-Boley, B., Chouraki, V., Heath, S., Zelenika, D., Fievet, N., Hannequin, D., Pasquier, F., Hanon, O., Brice, A., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100018 · Cited by 144
Almeida, S., Zhang, Z., Coppola, G., Mao, W., Futai, K., Karydas, A., Geschwind, M. D., Tartaglia, M. C., Gao, F., Gianni, D., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.007 · Cited by 140
Ando, K., Brion, J.-P., Stygelbout, V., Suain, V., Authelet, M., Dedecker, R., Chanut, A., Lacor, P., Lavaur, J., Sazdovitch, V., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1111-z · Cited by 136
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · cited 2×
“…have a frequency in the population of 8.4% (ε2), 77.9% (ε3), and 13.7% (ε4), the frequency of the APOE ε4 variant (APOE4) is increased to at least 40% in sporadic AD patients (Farrer et al., 1997) making it the greatest known risk factor for sAD (Kanekiyo et al., 2014; Lambert et al., 2013).”
BackgroundInfluentialFong, H., Wang, C., Knoferle, J., Walker, D., Balestra, M. E., Tong, L. M., Leung, L., Ring, K. L., Seeley, W. W., Karydas, A., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.08.001 · Cited by 122
The Neuron Identity Problem: Form Meets Function
Fishell, G., & Heintz, N. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.035 · Cited by 115
Unique transcriptome signature of mouse microglia
Beutner, C., Linnartz‐Gerlach, B., Schmidt, S. V., Beyer, M., Mallmann, M. R., Staratschek‐Jox, A., Schultze, J. L., & Neumann, H. (2013) · Glia · doi:10.1002/glia.22524 · Cited by 112
Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients
Jang, J., Kang, H., Kim, H., Kim, J. Y., Huh, Y. J., Kim, D., Yoo, J., Lee, J., Lim, B., Lee, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22486 · Cited by 109 · cited 1×
“…of heterogeneous cultures (Hu et al., 2009; Kim et al., 2012; Swistowski et al., 2010) or as the result of concerted efforts to generate these particular cell types (Douvaras et al., 2014; Jang et al., 2011; Ogawa et al., 2011; Pouya et al., 2011; S. Wang et al., 2013; X.Y. Wang et al., 2013).”
BackgroundYoshida, M., Kitaoka, S., Egawa, N., Yamane, M., Ikeda, R., Tsukita, K., Amano, N., Watanabe, A., Morimoto, M., Takahashi, J., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.010 · Cited by 102 · cited 2×
“, 2011), spinal muscular atrophy (Ebert et al., 2009; Yoshida et al., 2015), ADA-SCID, Gaucher disease type III, Duchenne muscular dystrophy, Becker muscular dystrophy, Down syndrome, Juvenile diabetes mellitus, Huntington disease (Consortium, 2012; N.”
BackgroundBlockage of CR1 prevents activation of rodent microglia
Crehan, H., Hardy, J., & Pocock, J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.02.003 · Cited by 98 · cited 5×
“…CD33 and CLU (Ando et al., 2013; Antunez et al., 2011; Bertram et al., 2008; Bradshaw et al., 2013; Calero et al., 2000; Corneveaux et al., 2010; Crehan et al., 2013; Deng et al., 2012; Guerreiro et al., 2013; Harold et al., 2009; Hollingworth et al., 2011; Jonsson et al., 2013; Lambert et al.,…”
BackgroundInfluentialGeneration of microglial cells from mouse embryonic stem cells
Beutner, C., Roy, K., Linnartz, B., Napoli, I., & Neumann, H. (2010) · Nature Protocols · doi:10.1038/nprot.2010.90 · Cited by 85
Krantic, S., Isorce, N., Mechawar, N., Davoli, M. A., Vignault, E., Albuquerque, M., Chabot, J.-G., Moyse, E., Chauvin, J.-P., Aubert, I., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110830 · Cited by 78 · cited 2×
“…of inhibitory neurons is of particular interest for AD research, since both inhibitory and excitatory neurons are affected (Hazra et al., 2013; Krantic et al., 2012), and inhibitory interneurons, such as parvalbuminergic cells, play crucial roles in orchestrating large networks crucial to…”
BackgroundMurray, A., Letourneau, A., Canzonetta, C., Stathaki, E., Gimelli, S., Sloan-Bena, F., Abrehart, R., Goh, P., Lim, S., Baldo, C., et al. (2015) · Stem Cells · doi:10.1002/stem.1968 · Cited by 78
Yoshimizu, T., Pan, J. Q., Mungenast, A. E., Madison, J. M., Su, S., Ketterman, J., Ongur, D., McPhie, D., Cohen, B., Perlis, R., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.181 · Cited by 21
Self-citation
Cited by
APP mouse models for Alzheimer’s disease preclinical studies.
Sasaguri, H., Nilsson, P., Hashimoto, S., Nagata, K., Saito, T., De Strooper, B., Hardy, J., Vassar, R., Winblad, B., & Saido, T. C. (2017) · The EMBO Journal · doi:10.15252/embj.201797397 · Cited by 793
Li, L., Chao, J., & Shi, Y. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2713-x · Cited by 89
“PSEN1 and APP mutations for familial AD and SOR1 for sporadic AD have also been modeled using AD patient iPSC-derived neurons (Mungenast et al. 2016; as also summarized by Shi et al. 2017).”
Ralvenius, W. T., Andresen, J. L., Huston, M. M., Penney, J., Bonner, J. M., Fenton, O. S., Langer, R., & Tsai, L. (2024) · Advanced Materials · doi:10.1002/adma.202309225 · Cited by 78
Self-citationSmit, T., Deshayes, N. A. C., Borchelt, D. R., Kamphuis, W., Middeldorp, J., & Hol, E. M. (2021) · Glia · doi:10.1002/glia.23981 · Cited by 71
Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model
Manos, J. D., Preiss, C. N., Venkat, N., Tamm, J., Reinhardt, P., Kwon, T., Wu, J., Winter, A. D., Jahn, T. R., Yanamandra, K., et al. (2022) · iScience · doi:10.1016/j.isci.2021.103658 · Cited by 36
Metadata
- Authors
- Mungenast, A. E., Siegert, S., & Tsai, L.-H.
- Venue
- Molecular and Cellular Neuroscience
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 73
- Pages
- 13-31
- ISSN
- 1044-7431 (ISSN-L)
- OpenAlex
- W2185060905
- Cited by
- 127
- References
- 134
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.